Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to <18 Years of Age with ...
Individual investors account for 39% of FreightCar America, Inc.'s (NASDAQ:RAIL) ownership, while institutions account for 35%
If you want to know who really controls FreightCar America, Inc. (NASDAQ:RAIL), then you'll have to look at the makeup of its share registry. With 39% stake, individual investors possess the maximum ...